Dosing of Subcutaneous Unfractionated Heparin (Mini-Heparin) for VTE Prophylaxis
Use unfractionated heparin (UFH) 5,000 units every 8 hours (three times daily) for VTE prophylaxis in hospitalized medical patients and most surgical patients, particularly those with cancer. Reserve the 2,500 unit dose exclusively for the initial preoperative dose in surgical patients, followed by 5,000 units daily postoperatively.
Specific Dosing Algorithms
For Hospitalized Medical Patients (Including Cancer Patients)
- Standard dose: 5,000 units subcutaneously every 8 hours 1, 2
- Continue throughout hospitalization or until fully ambulatory
- This three-times-daily regimen is superior to twice-daily dosing for preventing clinically significant VTE events (proximal DVT and PE), though it carries higher bleeding risk 3
For Surgical Patients
Standard-risk surgery:
- 2,500 units 2-4 hours preoperatively, then 5,000 units once daily postoperatively 2
High-risk surgery (especially cancer surgery):
- 5,000 units 2 hours before surgery, then 5,000 units every 8-12 hours for 7-10 days minimum 2, 4
- For cancer patients undergoing major abdominal/pelvic surgery: extend prophylaxis up to 30 days postoperatively 5
For Low Body Weight Patients (<50 kg)
- Reduce to 5,000 units every 12 hours (twice daily) 6
- This reduced-dose strategy significantly decreases composite bleeding (5% vs 12.5%, p=0.02) while maintaining similar VTE protection
When UFH is Superior to Enoxaparin (Clexane)
UFH is preferred over LMWH in these specific situations:
Severe renal impairment (CrCl <30 mL/min) 7, 1
- UFH undergoes hepatic metabolism, not renal clearance
- Enoxaparin accumulates dangerously in renal failure
Anticipated need for rapid reversal 7
- Protamine sulfate fully reverses UFH
- LMWH reversal is incomplete and unpredictable
Patients requiring frequent procedures or at high bleeding risk 7
- UFH's shorter half-life (1-2 hours vs 4-5 hours for enoxaparin) allows better procedural timing
- Can hold 4-6 hours before procedure vs 12-24 hours for LMWH
Cost-constrained settings 8
- UFH costs approximately $1.00-$3.00 per day
- Enoxaparin costs $3.49-$12.21 per day
Patients with body weight <50 kg when LMWH dosing is uncertain 7, 6
When Enoxaparin is Superior to UFH
In most other clinical scenarios, enoxaparin is preferred 2, 5, 9:
- Once-daily dosing improves compliance and nursing efficiency
- More predictable pharmacokinetics with weight-based dosing
- Lower risk of heparin-induced thrombocytopenia (HIT) - UFH causes HIT in up to 5% vs <1% with LMWH 10, 7
- Superior efficacy in stroke patients: enoxaparin reduced VTE by 43% compared to UFH (10% vs 18%, p=0.0001) 9
- Better outcomes in critically ill patients: UFH associated with higher mortality (HR 2.04, p=0.019) 11
Critical Dosing Pitfalls
Never use 5,000 units twice daily (every 12 hours) as standard prophylaxis - this regimen is less effective than three-times-daily dosing for preventing proximal DVT and PE 2, 3. The exception is low body weight patients (<50 kg) where reduced dosing is appropriate 6.
The 2,500 unit dose is NOT for routine prophylaxis - it serves only as the initial preoperative dose in surgical patients, followed by higher maintenance dosing 2, 8.
Monitoring Requirements
- Platelet counts every 2-3 days from day 4-14 to screen for HIT 10, 7
- No routine aPTT monitoring needed for prophylactic dosing 4
- Hemoglobin/hematocrit and occult blood testing periodically throughout therapy 4